'Double whammy' for Roche as manufacturing patent losses loom
IN -

ZURICH (Reuters) - Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed.

Loading...

Related Articles